{"nct_id":"NCT01857193","title":"Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2013-09-06","start_date_type":"ACTUAL","primary_completion_date":"2018-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2020-04-16","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}